Wegovy launches in Australia The manufacturer assured GPs supply planning has been its priority amid critical Ozempic shortages, but concerns remain over Wegovy’s availability.
Mounting evidence for sugar tax success Daily sugar intake fell by 11 g in adults one year after the UK rolled out a levy, as calls to introduce the tax in Australia gain momentum.
Holistic patient care key for overweight and obesity New education for GPs supporting patients with overweight and obesity aligns with the latest Red Book recommendations.
Body fat over BMI for obesity diagnosis: Study Researchers say doctors must ditch BMI as a diagnosis tool as it is excluding patients in need, instead calling for the use of waist-to-height ratios.
Sugary drink tax could raise billions: Parliamentary Budget Office Data has shed light on the significant economic benefits a proposed 20% levy could have, while GPs spruik its potential health benefits.
‘Absolutely tiny’ Federal obesity funding challenged Questions have been raised about why no weight loss drugs are on the PBS, as research highlights the lack of funding for obesity prevention.
Semaglutide shortage sparks patient demands for alternatives But in Australia, the new drug generating the most interest is still in its infancy – and not yet listed on the PBS.
What GPs need to know about obesity and its treatment SPONSORED: Obesity is a global epidemic caused by many factors. The disease, and how surgery and adjunct therapies fit in, should be understood.
Viral weight loss drug linked to pancreatitis Semaglutide could be putting patients at greater risk of severe gastrointestinal complications when used for obesity management.
WONCA obesity panel set to tackle growing issue An international group of experts will explore various elements of a chronic health issue that is becoming increasingly prevalent.